Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study

By Kim Hyo-Soo   Wu Yangfeng   Lin Shing-Jong   Deerochanawong Chaicharn   Zambahari Robaayah   Zhao Liancheng   Zhang Qiaoyi   Yan Peter  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1951-1963

Informa Healthcare

Access to resources Recommend Favorite

Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy

By Shepherd James   Packard Chris   Littlejohn Thomas W.   Walker James   Stein Evan A.   Smith Karen   Kallend David   Blasetto James W.  

Current Medical Research and Opinion, Vol. 20, Iss. 10, 2004-10 ,pp. : 1571-1578

Informa Healthcare

Access to resources Recommend Favorite

Adherence to single-pill combination versus multiple-pill combination lipid-modifying therapy among patients with mixed dyslipidemia in a managed care population

By Kamat Siddhesh A.   Bullano Michael F.   Chang Chun-Lan   Gandhi Sanjay K.   Cziraky Mark J.  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 961-968

Informa Healthcare

Access to resources Recommend Favorite

Lipid‐lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic

By  

INTERNAL MEDICINE JOURNAL, Vol. 48, Iss. 2, 2018-02 ,pp. : 201-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

New Advances in Lipid-Modifying Therapies for Reducing Cardiovascular Risk

By  

Cardiology, Vol. 97, Iss. 2, 2002-04 ,pp. : 59-66

Karger

Access to resources Recommend Favorite